Tag: biopharma

As part of the acquisition, Sun Pharma acquires UNLOXCYTTM, the first and only FDA-approved anti-PD-L1 treatment for advanced cutaneous squamous cell carcinoma

Dr Ramaswamy's presentation highlighted the potential of these molecules to accelerate drug discovery by enabling targeted protein degradation with enhanced specificity and efficiency

Bio-AI hubs are proposed to be established across academia and industry to provide critical and novel research leads

The Cover Story analyses the potential impact of significant uncertainty due to the proposed reciprocal tariffs with insights from Vishal Dhikale, Associate Vice President, Avalon Consulting. Read interview of Puneeth Kumar KT, Business Director for Planetary Health Biosolutions, Novonesis South Asia and Expert Insights by Mahesh Ramanujam, President & CEO, Global Network for Zero; and Dr Vidhi Bhanushali, CEO and Co-founder, scanO.

Over the last 24 years, the Company's sales has grown from Rs 478 crores to Rs 19,022 crores, a CAGR of 17%

ThRabis® was launched in April 2022 and has since been rolled out in multiple countries, offering a simpler, shorter vaccination schedule

The event was supported by the National Biopharma Mission, BIRAC, and Institution’s Innovation Council (IIC)

In the spirit of Health Month, Leucine Rich Bio sparks the only Indian platform dedicated exclusively to the future of gut health and microbiome science

The Cover Story analyzes the blockbuster opportunity for India's biopharma industry. Read interviews of Dr Cyrus Karkaria, President-Biotechnology, Lupin Limited; Sachin Joshi, MD & Founder, PharmNXT Biotech; Mandeep Singh Kumar, MD and Vice President, Medtronic India; and Harshvardhan Bhagchandka, President, IPL Biologicals

Awards highlight Avantor's commitment to the biopharma industry